{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Apoptosis",
      "Cell signaling",
      "MDM2",
      "Metabolism",
      "TP53"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "37314603",
  "DateCompleted": {
    "Year": "2023",
    "Month": "07",
    "Day": "31"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "08",
    "Day": "29"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2023",
        "Month": "06",
        "Day": "14"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1007/s11033-023-08512-3"
    ],
    "Journal": {
      "ISSN": "1573-4978",
      "JournalIssue": {
        "Volume": "50",
        "Issue": "8",
        "PubDate": {
          "Year": "2023",
          "Month": "Aug"
        }
      },
      "Title": "Molecular biology reports",
      "ISOAbbreviation": "Mol Biol Rep"
    },
    "ArticleTitle": "MDM2- an indispensable player in tumorigenesis.",
    "Pagination": {
      "StartPage": "6871",
      "EndPage": "6883",
      "MedlinePgn": "6871-6883"
    },
    "Abstract": {
      "AbstractText": [
        "Murine double minute 2 (MDM2) is a well-recognized molecule for its oncogenic potential. Since its identification, various cancer-promoting roles of MDM2 such as growth stimulation, sustained angiogenesis, metabolic reprogramming, apoptosis evasion, metastasis, and immunosuppression have been established. Alterations in the expression levels of MDM2 occur in multiple types of cancers resulting in uncontrolled proliferation. The cellular processes are modulated by MDM2 through transcription, post-translational modifications, protein degradation, binding to cofactors, and subcellular localization. In this review, we discuss the precise role of deregulated MDM2 levels in modulating cellular functions to promote cancer growth. Moreover, we also briefly discuss the role of MDM2 in inducing resistance against anti-cancerous therapies thus limiting the benefits of cancerous treatment."
      ],
      "CopyrightInformation": "\u00a9 2023. The Author(s)."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Biosciences, COMSATS University, Islamabad, 45550, Pakistan."
          }
        ],
        "LastName": "Zafar",
        "ForeName": "Aasma",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Biosciences, COMSATS University, Islamabad, 45550, Pakistan."
          }
        ],
        "LastName": "Khan",
        "ForeName": "Muhammad Jawad",
        "Initials": "MJ"
      },
      {
        "Identifier": [
          "0000-0002-3542-3383"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 20057, Washington, DC, U.S.. a.naeem@qu.edu.qa."
          },
          {
            "Identifier": [],
            "Affiliation": "Qatar University Health, Qatar University, P.O. Box 2713, Doha, Qatar. a.naeem@qu.edu.qa."
          }
        ],
        "LastName": "Naeem",
        "ForeName": "Aisha",
        "Initials": "A"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Netherlands",
    "MedlineTA": "Mol Biol Rep",
    "NlmUniqueID": "0403234",
    "ISSNLinking": "0301-4851"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "EC 2.3.2.27",
      "NameOfSubstance": "Proto-Oncogene Proteins c-mdm2"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Tumor Suppressor Protein p53"
    },
    {
      "RegistryNumber": "EC 2.3.2.27",
      "NameOfSubstance": "MDM2 protein, human"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mice"
    },
    {
      "QualifierName": [
        "genetics",
        "metabolism"
      ],
      "DescriptorName": "Proto-Oncogene Proteins c-mdm2"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Carcinogenesis"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Cell Transformation, Neoplastic"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Protein Processing, Post-Translational"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Tumor Suppressor Protein p53"
    }
  ],
  "CoiStatement": "No potential conflict of interest was reported by the author(s)."
}